© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
NSCLC
NSCLC Care That Doesn’t Follow NCCN Guidelines is 27% More Costly
May 21, 2021
CVS Health research shows $7,084 cost disadvantage to care that is not "concordant" with National Comprehensive Care Network guidelines.
Lung Cancer Screening Has Had Few Takers. Will Updated Recommendations Make a Difference?
May 20, 2021
A small fraction of those who were eligible under previous U.S. Preventive Services Task Force recommendations were screened with low-dose CT scans. New recommendations will make an additional 6.4 million Americans eligible, but a number of barriers to screening remain.
How the Menthol Cigarette Ban May Affect the African American Smoking Paradox
May 05, 2021
The prevalence of smoking among African American young adults “catches up” with other groups despite the low rate among Black youth. The ban on menthol may affect this and other aspects of smoking patterns among Black Americans.
KRAS Mutation Could Guide Treatment Decisions in Nonsmall Cell Lung Cancer
May 04, 2021
Chemo in combination with immunotherapy was preferable to immunotherapy alone in patients with a mutation of the KRAS gene and high levels of programmed cell death ligand 1, according to findings reported in JAMA Oncology.
Much Ado About MET for Precision Medicine in NSCLC, Review Finds
April 25, 2021
FDA has recently approved therapies targeting MET exon 14 skipping mutations.
Amgen Testing Program Could Identify NSCLC Patients With KRAS Biomarker
April 23, 2021
Biomarker status can help clinicians and patients make informed, personalized treatment decisions, whether the choice is an FDA-approved targeted therapy or a clinical trial.
Researchers Find “Medicare” Spike of Diagnoses of Lung, Other Common Cancers
April 02, 2021
Diagnoses spike in people's 65th year when most Americans become newly eligible for Medicare coverage.
Study Identified 25 Genetic Variants Linked with Lung Cancer Risk
April 01, 2021
Although smoking is the predominate risk factor for lung cancer, about 1 in 5 cases cases are believed to be linked to genetic factors.
Born In the USA Not an Advantage for Overall Survival From NSCLC
March 27, 2021
City of Hope researchers find longer overall survival rates among nonsmall cell lung cancer patients (NSCLC) who are immigrants. Could this be another instance of the healthy immigrant paradox?
New Lung Cancer Screening Recommendations Can Reach More Patients But Won't Remove All Barriers
March 11, 2021
The U.S. Preventative Services Task Force recently released an updated recommendation addressing lung cancer screening criteria at a sooner rate starting at 50-years-old rather than 55. The task force says this expansion will be especially helpful to those who face disparities to screening. Although, it won’t cover all disparities.